SlidesetHIVRSVCOVID-19Inflammasome Activation in Acute COVID-19 - Judy Lieberman, MD, PhDView Slideset
SlidesetHIVRSVCOVID-19Coagulopathy in Acute Viral Infections - COVID-19 - Yogen Kanthi, MD, FAHA, FSVMView Slideset
SlidesetHIVRSVCOVID-19Characterizing and Targeting Acute Inflammation Following SARS-CoV-2 Infection- Mirko Paiardini, PhDView Slideset
SlidesetHIVRSVCOVID-19Abstract 1: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality - Joseph RoccoView Slideset
SlidesetHIVRSVCOVID-19Abstract 2: Clinical Rebound of COVID-19 Following Nirmatrelvir/Ritonavir Is Not Associated With Delayed Immune Response or Severe Disease - Brian EplingView Slideset
SlidesetHIVRSVCOVID-19Multisystem Inflammatory Syndrome in Children (MIS-C) Post-SARS-CoV-2 Infection - Carrie LucasView Slideset
SlidesetHIVRSVCOVID-19Cardiovascular Issues in Acute / Chronic HIV and COVID-19 - Steven Grinspoon, MDView Slideset
SlidesetHIVRSVCOVID-19Contribution of Adipose Tissue to Chronic Inflammation - Christine Bourgeois, Pharm.D., PhDView Slideset
SlidesetHIVRSVCOVID-19Abstract 3: Macrophage Arterial Infiltration Relates to Plaque Type and Immune Activation in HIV - Steven GrinspoonView Slideset
SlidesetHIVRSVCOVID-19Long COVID-19 - Immunological - Anthony Kelleher, MBBS, PhD, FRACP, FRCPAView Slideset